{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:37:14Z","timestamp":1790962634789,"version":"4.1.0"},"reference-count":88,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","funder":[{"DOI":"10.13039\/501100020472","name":"Alport Foundation of Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020472","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Autosomal dominant Alport syndrome results from heterozygous pathogenic variants in\n                      <jats:italic toggle=\"yes\">COL4A3<\/jats:italic>\n                      or\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      and is the most common monogenic kidney disease, affecting approximately 1% of the population. It is characterized by persistent glomerular hematuria, a thinned glomerular basement membrane, and a family history of kidney disease. The typical Alport hearing loss and ocular abnormalities are not present. Autosomal dominant Alport syndrome is common in cohorts with hematuria, proteinuria, steroid-resistant nephrotic syndrome, kidney cysts, or kidney failure. Clinical features vary even in family members with the same genetic change. Overall, only two thirds of people with a heterozygous pathogenic\n                      <jats:italic toggle=\"yes\">COL4A3<\/jats:italic>\n                      or\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      variant have hematuria because of incomplete penetrance. Missense variants that result in Gly substitutions are associated with proteinuria more often than truncating changes, which is different from X-linked disease. However missense variants are not consistently associated with kidney failure or the age at kidney failure. Sometimes, genetic testing is negative even where clinicians strongly suspect autosomal dominant Alport syndrome. Genetic testing distinguishes autosomal dominant Alport syndrome from X-linked disease, which is less common but has a higher risk of kidney failure. Autosomal dominant Alport syndrome with more severe features must also be distinguished from digenic disease especially where only one of the two causative variants is identified. People with autosomal dominant Alport syndrome should be monitored for increased albuminuria and treated from its onset with angiotensin-converting enzyme inhibitors and, if necessary, sodium-glucose cotransporter 2 inhibitors. Genetic testing is currently recommended for all first-degree family members whether or not they have hematuria.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000001158","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:00:22Z","timestamp":1779465622000},"page":"1828-1839","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Autosomal Dominant Alport Syndrome"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6813-0288","authenticated-orcid":false,"given":"Judy","family":"Savige","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0699-960X","authenticated-orcid":false,"given":"Mary","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"7","key":"B1-20260826","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/qjmed\/hcx030","article-title":"Lessons learned from a multidisciplinary renal genetics clinic","volume":"110","author":"Alkanderi","year":"2017","journal-title":"QJM."},{"issue":"8","key":"B2-20260826","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00467-022-05846-1","article-title":"Clinical and diagnostic utility of genomic sequencing for children referred to a kidney genomics clinic with microscopic hematuria","volume":"38","author":"Shanks","year":"2023","journal-title":"Pediatr Nephrol."},{"issue":"3","key":"B3-20260826","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00467-024-06538-8","article-title":"Detection of Alport gene variants in children and young people with persistent hematuria","volume":"40","author":"Ng","year":"2025","journal-title":"Pediatr Nephrol."},{"issue":"3","key":"B4-20260826","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9343(81)90571-4","article-title":"Alport's syndrome. A report of 58 cases and a review of the literature","volume":"70","author":"Gubler","year":"1981","journal-title":"Am J Med."},{"key":"B5-20260826","first-page":"S20","article-title":"Alport's syndrome: experience at Hopital Necker","volume":"11","author":"Habib","year":"1982","journal-title":"Kidney Int Suppl."},{"issue":"4","key":"B6-20260826","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ki.1985.63","article-title":"Genetic heterogeneity of Alport syndrome","volume":"27","author":"Feingold","year":"1985","journal-title":"Kidney Int."},{"issue":"11","key":"B7-20260826","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2215\/CJN.03120322","article-title":"Digenic Alport syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B8-20260826","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport syndrome classification working group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int."},{"issue":"4","key":"B9-20260826","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1523-1755.2003.00234.x","article-title":"Thin basement membrane nephropathy","volume":"64","author":"Savige","year":"2003","journal-title":"Kidney Int."},{"issue":"5","key":"B10-20260826","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2009070784","article-title":"Genotype-phenotype correlation in X-linked Alport syndrome","volume":"21","author":"Bekheirnia","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"25","key":"B11-20260826","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport's syndrome, goodpasture's syndrome, and type IV collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med."},{"issue":"9","key":"B12-20260826","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B13-20260826","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00467-021-05312-4","article-title":"Whole exome sequencing identifies monogenic forms of nephritis in a previously unsolved cohort of children with steroid-resistant nephrotic syndrome and hematuria","volume":"37","author":"Xiao","year":"2022","journal-title":"Pediatr Nephrol."},{"issue":"2","key":"B14-20260826","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N Engl J Med."},{"issue":"7","key":"B15-20260826","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41436-021-01127-8","article-title":"The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation","volume":"23","author":"Schrezenmeier","year":"2021","journal-title":"Genet Med."},{"key":"B16-20260826","doi-asserted-by":"crossref","first-page":"1647695","DOI":"10.3389\/fmed.2025.1647695","article-title":"Coexisting genetic kidney disease explains many cases of \u201bfamilial\u2019 IgA nephropathy where the proband has biopsy-confirmed mesangial IgA deposits","volume":"12","author":"Li","year":"2026","journal-title":"Front Med."},{"key":"B17-20260826","article-title":"Monogenic kidney disease and monogenic diabetes are present in renal clinic patients with non-genetic diagnoses","author":"Huang","year":"2026","journal-title":"Sci Rep."},{"key":"B18-20260826","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000001106","article-title":"Alport: renaming an extended clinical spectrum","author":"Lennon","year":"2026","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B19-20260826","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3476(79)80710-6","article-title":"Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation","volume":"95","author":"Vehaskari","year":"1979","journal-title":"J Pediatr."},{"issue":"5","key":"B20-20260826","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2215\/CJN.13711021","article-title":"GWAS of hematuria","volume":"17","author":"Gagliano Taliun","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B21-20260826","doi-asserted-by":"crossref","first-page":"699","DOI":"10.5858\/2006-130-699-TGBMNI","article-title":"Thin glomerular basement membrane nephropathy: incidence in 3471 consecutive renal biopsies examined by electron microscopy","volume":"130","author":"Haas","year":"2006","journal-title":"Arch Pathol Lab Med."},{"issue":"10","key":"B22-20260826","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/genes13101779","article-title":"Mutation analysis of thin basement membrane nephropathy","volume":"13","author":"Hirabayashi","year":"2022","journal-title":"Genes (Basel)."},{"issue":"10","key":"B23-20260826","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ekir.2023.07.010","article-title":"The phenotypic spectrum of COL4A3 heterozygotes","volume":"8","author":"Solanki","year":"2023","journal-title":"Kidney Int Rep."},{"issue":"6","key":"B24-20260826","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/ndt\/gfae265","article-title":"Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN","volume":"40","author":"Torra","year":"2025","journal-title":"Nephrol Dial Transplant."},{"key":"B25-20260826","doi-asserted-by":"crossref","first-page":"1096869","DOI":"10.3389\/fmed.2023.1096869","article-title":"A founder COL4A4 pathogenic variant resulting in autosomal recessive Alport syndrome accounts for most genetic kidney failure in Romani people","volume":"10","author":"Plevova","year":"2023","journal-title":"Front Med (Lausanne)."},{"issue":"1","key":"B26-20260826","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.1038\/s41598-025-92520-9","article-title":"Pathogenic variants in the Alport genes are prevalent in the Singapore multiethnic population with highest frequency in the Chinese","volume":"15","author":"Lim","year":"2025","journal-title":"Sci Rep."},{"issue":"9","key":"B27-20260826","doi-asserted-by":"crossref","first-page":"e0161802","DOI":"10.1371\/journal.pone.0161802","article-title":"X-Linked and autosomal recessive Alport syndrome: pathogenic variant features and further genotype-phenotype correlations","volume":"11","author":"Savige","year":"2016","journal-title":"PLoS One."},{"issue":"4","key":"B28-20260826","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B29-20260826","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ndt\/17.7.1218","article-title":"Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling","volume":"17","author":"Gross","year":"2002","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B30-20260826","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/s41598-022-06525-9","article-title":"Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome","volume":"12","author":"Gibson","year":"2022","journal-title":"Sci Rep."},{"issue":"4","key":"B31-20260826","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.ajkd.2021.02.326","article-title":"Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study","volume":"78","author":"Furlano","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"B32-20260826","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/cge.14471","article-title":"Is there a dominant-negative effect in individuals with heterozygous disease-causing variants in COL4A3\/COL4A4?","volume":"105","author":"Riedhammer","year":"2024","journal-title":"Clin Genet."},{"issue":"6","key":"B33-20260826","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ckj\/sfz176","article-title":"Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: a systematic review","volume":"13","author":"Matthaiou","year":"2020","journal-title":"Clin Kidney J."},{"key":"R34-20260826","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/ndt\/gfaf011","article-title":"Exon location of glycine substitutions impacts kidney survival in autosomal dominant alport syndrome","volume":"40","author":"Pagniez","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"B35-20260826","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1053\/ajkd.2001.29217","article-title":"A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome","volume":"38","author":"Dagher","year":"2001","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"B36-20260826","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/j.ajkd.2022.09.012","article-title":"Risk of CKD following detection of microscopic hematuria: a retrospective cohort study","volume":"81","author":"Um","year":"2023","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B37-20260826","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/ndt\/gfh617","article-title":"Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian renal immunopathology group","volume":"20","author":"Frasca","year":"2005","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"B38-20260826","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000528243","article-title":"Thin basement membrane: an underrated cause of end-stage renal disease","volume":"147","author":"Uzzo","year":"2023","journal-title":"Nephron."},{"issue":"6","key":"B39-20260826","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1046\/j.1523-1755.2001.00721.x","article-title":"Red cell traverse through thin glomerular basement membranes","volume":"59","author":"Collar","year":"2001","journal-title":"Kidney Int."},{"issue":"5","key":"B40-20260826","doi-asserted-by":"crossref","first-page":"e0155255","DOI":"10.1371\/journal.pone.0155255","article-title":"Podocyte depletion in thin GBM and Alport syndrome","volume":"11","author":"Wickman","year":"2016","journal-title":"PLoS One."},{"issue":"3","key":"B41-20260826","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MNH.0b013e32835f7241","article-title":"Hematuria and risk for end-stage kidney disease","volume":"22","author":"Vivante","year":"2013","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"10","key":"B42-20260826","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00467-007-0622-z","article-title":"Familial hematuria","volume":"24","author":"Kashtan","year":"2009","journal-title":"Pediatr Nephrol."},{"issue":"3","key":"B43-20260826","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-022-05627-w","article-title":"Variants in genes coding for collagen type IV alpha-chains are frequent causes of persistent, isolated hematuria during childhood","volume":"38","author":"Alge","year":"2023","journal-title":"Pediatr Nephrol."},{"issue":"5","key":"B44-20260826","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1046\/j.1523-1755.2001.0590051670.x","article-title":"Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome","volume":"59","author":"Buzza","year":"2001","journal-title":"Kidney Int."},{"issue":"1","key":"B45-20260826","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-5347(05)65447-X","article-title":"The association of an increased urinary calcium-to-creatinine ratio, and asymptomatic gross and microscopic hematuria in children","volume":"167","author":"Parekh","year":"2002","journal-title":"J Urol."},{"issue":"9","key":"B46-20260826","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.34067\/KID.0003222020","article-title":"Approach to persistent microscopic hematuria in children","volume":"1","author":"Kallash","year":"2020","journal-title":"Kidney360."},{"issue":"5","key":"B47-20260826","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/j.ackd.2011.05.001","article-title":"The spectrum of polycystic kidney disease in children","volume":"18","author":"Dell","year":"2011","journal-title":"Adv Chronic Kidney Dis."},{"issue":"4","key":"B48-20260826","first-page":"151","article-title":"Thin membrane nephropathy: a clinico-pathological study","volume":"32","author":"Aarons","year":"1989","journal-title":"Clin Nephrol."},{"issue":"1","key":"B49-20260826","doi-asserted-by":"crossref","first-page":"F120","DOI":"10.1152\/ajprenal.00456.2015","article-title":"Albumin contributes to kidney disease progression in Alport syndrome","volume":"311","author":"Jarad","year":"2016","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6","key":"B50-20260826","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ki.2014.305","article-title":"Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis","volume":"86","author":"Malone","year":"2014","journal-title":"Kidney Int."},{"issue":"9","key":"B51-20260826","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1093\/ndt\/gfp158","article-title":"Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3\/COL4A4 genes associated with familial hematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis","volume":"24","author":"Pierides","year":"2009","journal-title":"Nephrol Dial Transplant."},{"issue":"9","key":"B52-20260826","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.ekir.2022.06.001","article-title":"Heterozygous pathogenic COL4A3 and COL4A4 variants (autosomal dominant Alport syndrome) are common, and not typically associated with end-stage kidney failure, hearing loss, or ocular abnormalities","volume":"7","author":"Savige","year":"2022","journal-title":"Kidney Int Rep."},{"issue":"3","key":"B53-20260826","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1523-1755.2004.00835.x","article-title":"Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-The Limburg renal registry","volume":"66","author":"van Paassen","year":"2004","journal-title":"Kidney Int."},{"issue":"9","key":"B54-20260826","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/ndt\/gfae031","article-title":"Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants","volume":"39","author":"Furlano","year":"2024","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B55-20260826","doi-asserted-by":"crossref","first-page":"100815","DOI":"10.1016\/j.xkme.2024.100815","article-title":"Kidney cysts in children with Alport syndrome: a report of 3 cases","volume":"6","author":"Chang","year":"2024","journal-title":"Kidney Med."},{"issue":"7","key":"B56-20260826","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/ndt\/gfae290","article-title":"Challenging the narrative of Alport syndrome spectrum: no link with cystic phenotype","volume":"40","author":"Pagniez","year":"2025","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"B57-20260826","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semnephrol.2005.01.006","article-title":"Pathology of thin basement membrane nephropathy","volume":"25","author":"Foster","year":"2005","journal-title":"Semin Nephrol."},{"issue":"3","key":"B58-20260826","first-page":"105","article-title":"Abnormally thin glomerular basement membrane and the Goodpasture epitope","volume":"33","author":"Pettersson","year":"1990","journal-title":"Clin Nephrol"},{"issue":"2","key":"B59-20260826","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000063288","article-title":"Quantitative analysis of glomerular type IV collagen alpha3-5 chain expression in children with thin basement membrane disease","volume":"92","author":"Ueda","year":"2002","journal-title":"Nephron."},{"issue":"5","key":"B60-20260826","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/bjo.81.5.373","article-title":"Ocular abnormalities in thin basement membrane disease","volume":"81","author":"Colville","year":"1997","journal-title":"Br J Ophthalmol."},{"issue":"5","key":"B61-20260826","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI118893","article-title":"Benign familial hematuria due to mutation of the type IV collagen alpha4 gene","volume":"98","author":"Lemmink","year":"1996","journal-title":"J Clin Invest."},{"issue":"6","key":"B62-20260826","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.ajkd.2023.10.011","article-title":"Tips for testing adults with suspected genetic kidney disease","volume":"83","author":"Savige","year":"2024","journal-title":"Am J Kidney Dis."},{"issue":"8","key":"B63-20260826","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/gim.2015.181","article-title":"The psychological impact of genetic information on children: a systematic review","volume":"18","author":"Wakefield","year":"2016","journal-title":"Genet Med."},{"issue":"1","key":"B64-20260826","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00467-018-4121-1","article-title":"Alport syndrome: deducing the mode of inheritance from the presence of hematuria in family members","volume":"35","author":"Savige","year":"2020","journal-title":"Pediatr Nephrol."},{"issue":"3","key":"B65-20260826","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B66-20260826","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.kint.2023.05.006","article-title":"A wave of deep intronic mutations in X-linked Alport syndrome","volume":"104","author":"Boisson","year":"2023","journal-title":"Kidney Int."},{"key":"B67-20260826","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-026-01061-5","article-title":"\u201bMissing\u2019 disease-causing variants in Alport syndrome","author":"Savige","year":"2026","journal-title":"Nat Rev Nephrol."},{"issue":"2","key":"B68-20260826","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/ndt\/gfaf186","article-title":"Transition of patients with hereditary nephropathies from pediatric to adult care","volume":"41","author":"Gomez","year":"2026","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"B69-20260826","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/13816819709057125","article-title":"Ocular manifestations of autosomal recessive Alport syndrome","volume":"18","author":"Colville","year":"1997","journal-title":"Ophthalmic Genet."},{"issue":"8","key":"B70-20260826","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1681\/ASN.2007020241","article-title":"Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36","volume":"18","author":"Paterson","year":"2007","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B71-20260826","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ekir.2020.04.011","article-title":"Type IV collagen mutations in familial IgA nephropathy","volume":"5","author":"Li","year":"2020","journal-title":"Kidney Int Rep."},{"issue":"5","key":"B72-20260826","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/ndt\/11.5.791","article-title":"Clinical features in two patients with IgA glomerulonephritis and thin-basement-membrane disease","volume":"11","author":"Lanteri","year":"1996","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B73-20260826","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.ekir.2021.02.022","article-title":"Rare collagenous heterozygote variants in children with IgA nephropathy","volume":"6","author":"Cambier","year":"2021","journal-title":"Kidney Int Rep."},{"issue":"5","key":"B74-20260826","doi-asserted-by":"crossref","first-page":"e259500","DOI":"10.1136\/bcr-2023-259500","article-title":"Coexisting presentation of two rare genetic variants of autosomal dominant polycystic kidney disease and Alport syndrome","volume":"17","author":"Venda","year":"2024","journal-title":"BMJ Case Rep."},{"issue":"1","key":"B75-20260826","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00467-012-2138-4","article-title":"Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport syndrome research collaborative","volume":"28","author":"Kashtan","year":"2013","journal-title":"Pediatr Nephrol."},{"issue":"1","key":"B76-20260826","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2215\/CJN.04230321","article-title":"Guidelines for genetic testing and management of Alport syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"18","key":"B77-20260826","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1113\/jphysiol.2014.274449","article-title":"Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment","volume":"592","author":"Savige","year":"2014","journal-title":"J Physiol."},{"issue":"8","key":"B78-20260826","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2011.452","article-title":"Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations","volume":"81","author":"Temme","year":"2012","journal-title":"Kidney Int."},{"issue":"12","key":"B79-20260826","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1016\/j.ekir.2024.09.014","article-title":"SGLT2-Inhibition in patients with Alport syndrome","volume":"9","author":"Boeckhaus","year":"2024","journal-title":"Kidney Int Rep."},{"issue":"4","key":"B80-20260826","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ndt\/gfae180","article-title":"Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport","volume":"40","author":"Gross","year":"2025","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B81-20260826","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s44162-023-00022-x","article-title":"Finerenone and other future therapeutic options for Alport syndrome","volume":"2","author":"Pearce","year":"2023","journal-title":"J Rare Dis (Berlin)."},{"issue":"1","key":"B82-20260826","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s44162-024-00065-8","article-title":"GLP-1 receptor agonists-another promising therapy for Alport syndrome?","volume":"4","author":"Boeckhaus","year":"2025","journal-title":"J Rare Dis (Berlin)."},{"issue":"3","key":"B83-20260826","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40620-025-02252-2","article-title":"A retrospective study of kidney disease in Alport syndrome during and after pregnancy","volume":"38","author":"Kong","year":"2025","journal-title":"J Nephrol."},{"issue":"3","key":"B84-20260826","doi-asserted-by":"crossref","first-page":"e70045","DOI":"10.1002\/jgc4.70045","article-title":"Carrier screening for Alport syndrome: the clinical importance of heterozygosity for pathogenic or likely pathogenetic variants","volume":"34","author":"Souter","year":"2025","journal-title":"J Genet Couns."},{"issue":"5","key":"B85-20260826","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.kint.2024.01.034","article-title":"Reassuring pregnancy outcomes in women with mild COL4A3-5-related disease (alport syndrome) and genetic type of disease can aid personalized counseling","volume":"105","author":"Gosselink","year":"2024","journal-title":"Kidney Int."},{"issue":"9","key":"B86-20260826","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2215\/CJN.0000000769","article-title":"Pregnancy and long-term kidney function in CKD: a systematic review and meta-analysis","volume":"20","author":"Gosselink","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"9","key":"B87-20260826","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2215\/CJN.03550320","article-title":"Preimplantation genetic testing for monogenic kidney disease","volume":"15","author":"Snoek","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"key":"B88-20260826","doi-asserted-by":"crossref","first-page":"1201712","DOI":"10.3389\/fmed.2023.1201712","article-title":"What patients want to know about genetic testing for kidney disease","volume":"10","author":"Savige","year":"2023","journal-title":"Front Med (Lausanne)."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:04:58Z","timestamp":1787745898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":88,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000001158","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}